Monoclonal Antibody Therapy in Treating Patients With Leukemia
NCT00019227
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
NIH
Sponsor class
Conditions
Lymphoma
Radiation Toxicity
Interventions
DRUG:
pentetic acid calcium
RADIATION:
yttrium Y 90 daclizumab
Sponsor
National Cancer Institute (NCI)